Please login to the form below

Not currently logged in

New healthcare comms agency launches in London

Paradigm Communications will be managed by Porter Novelli


Omnicom company Porter Novelli has launched a new London-based healthcare communications agency, Paradigm Communications.

Lisa O'Sullivan and Neil McGregor-Paterson represent the senior team for the agency that aims to provide services for the pharmaceutical, health technology and associated health and wellbeing sectors.

Among the services on offer are patient advocacy group relations, stakeholder relations, market access, media relations, payer communications and public affairs.

"There is a growing need among health and wellness clients for experts who specialise in market access and advocacy communications," said McGregor-Paterson.

"The team at Paradigm Communications offers considerable expertise in these areas, which has been recognised by our current clients.

"In addition, in today's cost-constrained environment, health inequality remains a significant issue. At Paradigm Communications, we recognise the critical role industry can play in helping to address this through medicines, products and expertise," he added.

Prior to launching Paradigm, McGregor-Paterson held a number of senior positions at public relations and market access agencies including Porter Novelli, Ogilvy PR, Chandler Chicco Agency, Weber Shandwick and Shire Health New York.

Lisa O'Sullivan has been group PR director at The Partnership Agency, associate director at Resolute Communications, and has had stints at Shire Health, CPR Communications and EuroHealth PR/Say Communications.

11th June 2013

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...